Avalo Therapeutics Inc. (AVTX)
NASDAQ: AVTX
· Real-Time Price · USD
9.05
0.10 (1.12%)
At close: Aug 15, 2025, 3:59 PM
9.24
2.10%
After-hours: Aug 15, 2025, 07:50 PM EDT
Avalo Therapeutics Fail-to-Deliver
Total FTD Shares
385
Below Average
FTD / Avg. Volume
0.22%
Low Impact
1-Year Change
61.1%
Positive Trend
FTD Chart
As of Jul 14, 2025,
Avalo Therapeutics Inc. has
385
shares failed to deliver, representing 0.22%
of the average daily volume of
177,659
shares. Over the past year, the monthly average FTD is
53,021
shares, with the current level 99% below
the historical average, indicating
low
settlement pressure. The weighted FTD ratio below 1% suggests normal market making activity with adequate liquidity.
FTD History
| Date | Price | FTD Shares | % Change |
|---|---|---|---|
| Jul 14, 2025 | 4.9 | 385 | -95.06% |
| Jun 30, 2025 | 4.99 | 7.79K | +5942.64% |
| May 23, 2025 | 3.75 | 129 | -19.88% |
| Apr 30, 2025 | 4.98 | 161 | -72.80% |
| Mar 27, 2025 | 8.73 | 592 | +5.34% |
| Feb 28, 2025 | 7.31 | 562 | -66.27% |
| Jan 30, 2025 | 7.9 | 1.67K | +23700.00% |
| Dec 27, 2024 | 8.33 | 7 | -98.28% |
| Nov 29, 2024 | 9.55 | 407 | +11.81% |
| Oct 25, 2024 | 14.44 | 364 | -42.04% |
| Sep 30, 2024 | 9.5 | 628 | -27.82% |
| Aug 30, 2024 | 7 | 870 | +1833.33% |
| Jul 23, 2024 | 12.32 | 45 | +2150.00% |
| Jun 28, 2024 | 12.47 | 2 | -99.78% |
| May 31, 2024 | 11.69 | 920 | -85.62% |
| Apr 30, 2024 | 17.12 | 6.4K | +197.07% |
| Mar 28, 2024 | 21.75 | 2.15K | +844.30% |
| Feb 29, 2024 | 4.41 | 228 | -90.69% |
| Jan 31, 2024 | 4.65 | 2.45K | -92.72% |
| Dec 28, 2023 | 11.76 | 33.65K | -0.10% |
| Nov 30, 2023 | 16.8 | 33.68K | -88.11% |
| Oct 31, 2023 | 26.4 | 283.22K | +90.55% |
| Sep 29, 2023 | 29.04 | 148.63K | +635.85% |
| Aug 11, 2023 | 30.72 | 20.2K | +485.48% |
| Jul 31, 2023 | 48 | 3.45K | n/a |